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Abstract
Psychopathology is prevalent in Williams (WS), fragile X (FXS) and Prader–Willi (PWS) syndromes. However, little is 
known about the potential correlates of psychopathology in these groups. A questionnaire study was completed by 111 
caregivers of individuals with WS (n = 35); FXS (n = 50) and PWS (n = 26). Mean age was 26 years (range 12–57 years); 
74 (67%) were male. Multiple regression analyses indicated that higher rates of health problems and sensory impairments 
predicted higher psychopathology in WS (p < .0001). In PWS, poorer adaptive ability predicted higher overall psychiatric 
disturbance (p = .001), generalised anxiety (p = .006) and hyperactivity (p = .003). There were no significant predictors in 
FXS. This study highlights dissociations in the potential risk markers of psychopathology between genetic syndromes. 
Implications for intervention are discussed.
Keywords Williams syndrome · Prader–Willi syndrome · Fragile X syndrome · Psychopathology · Correlates
The prevalence of psychopathology in individuals with 
intellectual disabilities (ID) is estimated as being four to 
five times higher than in the general population (Matson 
and Shoemaker 2011). A number of syndromes associated 
with ID evidence differing profiles of psychopathology. 
For example, individuals with Prader–Willi syndrome are 
reported to have a high prevalence of psychotic illness (Soni 
et al. 2008), whilst social anxiety is associated with fragile 
X and Turners syndromes (Cordeiro et al. 2011; Lesniak-
Karpiak et al. 2003). Generalised anxiety and phobias are 
prominent in Williams syndrome (Dodd and Porter 2009; 
Leyfer et al. 2006; Royston et al. 2017) and separation anxi-
ety is common in Cornelia de Lange syndrome (Crawford 
et al. 2017). Study of psychopathological profiles and corre-
lates may help to inform causal models of psychiatric distur-
bance in individuals with ID. Cross syndrome comparisons 
also facilitate exploration of within-syndrome psychopatho-
logical risk, as well as identifying commonalities between 
genetic syndromes.
In this study we examine the nature and correlates of 
psychopathology in three syndromes that are broadly com-
parable for degree of ID: Williams (WS), fragile X (FXS) 
and Prader–Willi syndromes (PWS). WS is caused by a 
microdeletion of approximately 28 genes on chromosome 
7q11.23, with an estimated prevalence of up to 1 in 7500 
births (Ewart et al. 1993; Strømme et al. 2002). The WS 
phenotype is characterised by hyper-sociability, hypersensi-
tivity to sound (hyperacusis), attention deficits, impulsivity 
and emotional difficulties (Einfeld et al. 1997; Jones et al. 
2000; Levitin et al. 2005; Leyfer et al. 2006). FXS is caused 
by a fMR1 gene mutation at Xq27.3, with a prevalence of 1 
in 5000 men and 1 in 4000–6000 women (Coffee et al. 2009; 
Saldarriaga et al. 2014). Repetitive behaviour, attentional 
difficulties, social and sensory impairments and mental 
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health problems such as anxiety are common (Garber et al. 
2008; McLennan et al. 2011; Oakes et al. 2016; Rogers et al. 
2003). PWS results from the absence of the expression of the 
paternal gene on chromosome 15q11.2–q13, affecting 1 in 
15,000–30,000 individuals (Cassidy and Driscoll 2009; Cas-
sidy et al. 2012). This syndrome is associated with obses-
sions, compulsions, temper outbursts and anxiety (Cassidy 
et al. 2011; Dykens and Kasari 1997; Reddy and Pfeiffer 
2007). Further detailed descriptions of these syndromes can 
be found in reviews by Cassidy and Driscoll (2009); Maz-
zocco (2000) and Royston et al. (2019).
In each of these syndromes there is a heightened risk 
of developing psychopathology although the types of dis-
order differ between the groups. Thus, the prevalence of 
generalised anxiety disorder is high in WS and FXS but 
not PWS; rates of social anxiety disorder are elevated in 
FXS but not WS or PWS and there is a higher prevalence of 
obsessive–compulsive disorder in PWS but not FXS (Cord-
eiro et al. 2011; Dykens and Shah 2003; Leyfer et al. 2006; 
Royston et al. 2017). However, the profiles of psychopathol-
ogy in these syndromes and their correlates have not been 
compared directly using the same assessments.
Both within and between syndromes, identification of 
correlates or risk markers could provide information on 
putative causal pathways of psychopathology and may have 
implications for early intervention. There has been little 
investigation of potential correlates of psychopathology in 
WS, FXS or PWS and among the few variables that have 
been explored, there seems to be no relationship with gen-
der (Cordeiro et al. 2011; Einfeld et al. 1999; Dykens and 
Kasari 1997; Riby et al. 2014; Stinton et al. 2010), and data 
on the association with age and intellectual functioning are 
inconsistent (Cordeiro et al. 2011; Dodd and Porter 2009; 
Dykens 2004; Dykens and Cassidy 1995; Dykens and Kasari 
1997; Hessl et al. 2001; Lesniak-Karpiak et al. 2003; Stinton 
et al. 2010). However, in each of these syndromes there is 
a raised prevalence of physical health problems; significant 
difficulties in sensory processing are also typical (Levitin 
et al. 2005; Rogers et al. 2003; Stauder et al. 2002). Audi-
tory sensory sensitivities, in particular, are prevalent in all 
groups (Ethridge et al. 2016; Levitin et al. 2005; Stauder 
et al. 2002), and in WS, for example, there is evidence that 
that many specific phobias are related to hypersensitivity to 
noise (Leyfer et al. 2006; Royston et al. 2017). Neverthe-
less, there has been no research into the impact of these 
characteristics, despite both poor physical health and sen-
sory processing difficulties being potentially influential in 
the development of anxiety, depression and other disorders 
(Pober and Morris 2007; Uljarević et al. 2018).
Discrepancies in reported rates of psychopathology 
across syndromes, and variability in the reported correla-
tions with other factors may reflect differences in assess-
ment methodologies and categorisation systems. Typically, 
psychopathology in individuals with ID is examined using 
assessments based on diagnostic taxonomies developed for 
the general population and judgments about the presence or 
absence of a disorder are based on predefined symptoms and 
criteria (American Psychiatric Association 2013). However, 
the applicability of this approach for individuals with ID is 
uncertain, due to possible differences in clinical features and 
behaviours compared with individuals in the general popu-
lation. In recent years, growing recognition that disorders 
may exist along a continuum from normality to abnormality 
(Sanislow et al. 2010) has resulted in a move towards the use 
of dimensional frameworks to assess psychopathology. This 
approach allows for specification of disorder severity and is 
more resistant to minor fluctuations in psychopathological 
difficulties (Clark et al. 1995; Watson 2005). Dimensional 
assessments are also often developed using empirical litera-
ture and psychometric research to form assessment subscales 
and categories that are not pre-defined and may be specific 
to certain groups, and thus are potentially more relevant to 
psychopathology in individuals with ID.
In this study, we used both categorical and dimensional 
questionnaire measures to explore phenomenology and 
cross-syndrome differences in individuals with WS, FXS 
and PWS. We also investigated associations between psy-
chopathology and age, adaptive ability (as a proxy measure 
of intellectual functioning), health problems and auditory 
sensory processing. Our focus was specifically on adoles-
cents and adults because of the high rates of mental health 
problems in these age groups.
The aims of the study were:
1) To describe the profile of psychopathology in individu-
als with WS, FXS and PWS and identify differences in 
profiles between the syndromes.
We hypothesised that social anxiety would be signifi-
cantly higher in FXS; generalised anxiety would be higher 
in FXS and WS compared to PWS; obsessive–compulsive 
behaviour would be higher in PWS.
2) To assess whether age, adaptive ability, health difficul-
ties and auditory sensory processing impairments are 
associated with psychological disturbance within syn-
dromes.
We hypothesised that health difficulties and auditory sen-
sory processing impairments would be positively associated 
with psychopathology for all groups.
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Methods
Participants
Participants were recruited from the Cerebra Centre for 
Neurodevelopmental Disorders (CCND) participant data-
base (response rate: 38% for PWS, 18% for FXS and 36% 
for WS). Participants were also recruited from the Fragile 
X Society, the Williams Syndrome Foundation in the UK, 
the Canadian Association for Williams Syndrome and the 
Williams Syndrome Registry (www.willi ams-syndr ome.
org/regis try), administrated by the Williams Syndrome 
Association, USA.
A total of 132 families participated in the survey. Partic-
ipants were included if they had completed at least 25% of 
the questionnaire survey (10 individuals excluded) and the 
person they cared for was over the age of 12 (2 excluded). 
Inclusion criteria were a confirmed genetic diagnosis from 
a clinician (clinical geneticist, paediatrician or general 
practitioner) or a positive result from prior genetic testing. 
Individuals with mobility difficulties (n = 3) and limited 
verbal ability (speaks/signs fewer than 30 words, n = 5) 
were excluded to ensure better group matching. Due to the 
tendency for higher cognitive functioning in females with 
FXS (Bartholomay et al. 2019), only males with FXS were 
included in the study. This resulted in a total of 110 par-
ticipants (mean age = 26.53, SD = 10.36, range:12–57, 74 
male). There were 35 participants in the WS sample (mean 
age = 25.51, SD = 12.39, range: 12–57, 14 male), 49 in the 
FXS sample (mean age = 27.08, SD = 9.18, range: 12–50, 
all male) and 26 in the PWS group (mean age = 26.85, 
SD = 9.77, range: 12–47, 11 male).
This study was conducted as part of a larger study 
investigating behavioural phenotypes in neurodevelopmen-
tal disorders. The study was approved by the NHS Coven-
try and Warwickshire REC committee as an amendment 
to an existing ethics application (reference: 10/H1210/01).
Measures
Waisman Activities of Daily Living Scale
The Waisman Activities of Daily Living Scale (W-ADL; 
Maenner et al. 2013) is designed for adolescents and adults 
(over the age of 10) with ID and examines ability level and 
independence in carrying out daily living activities. This 
measure of adaptive skills can be used as a proxy measure 
of functional ability. The informant scale has 17 items, 
each rated on a three-point Likert scale; 2 = ‘Independ-
ent or does on own’, 1 = ‘does with help’ and 0 = ‘does 
not do at all’. The scale is reported to have high internal 
consistency in a sample of adolescents and adults aged 
10–52 years (Cronbach’s alphas ranging from .88–.94).
Health Questionnaire
The Health questionnaire (Hall et al. 2008) examines the 
presence and severity of current (in the last month) and life-
time health problems in children and adults. The question-
naire consists of 15 health problems scored on a scale of 
0 = “never affected” to 3 = “severely affected”. Scores are 
summed to obtain an overall health score. Item level reli-
ability was .72 for lifetime problems and .76 for current 
problems (Hall et al. 2008).
Developmental Behaviour Checklist
The Developmental Behaviour Checklist (DBC; Einfeld and 
Tonge 1995) measures emotional and behavioural disorders 
in individuals with intellectual disabilities over the past six 
months. Behaviour is scored as 0 = ‘not true as far as you 
know’, 1 = ‘somewhat or sometimes true’ or 2 = ‘very true 
or often true’. The DBC-P is the parent version for indi-
viduals under the age of 18 and comprises 95 items and five 
subscales; disruptive/antisocial, self-absorbed, communi-
cation, anxiety and social relating. It has good test–retest 
(.83) and inter-rater reliability (Einfeld and Tonge 1995). 
The DBC-A is the adult version suitable for individuals over 
the age of 18. This version contains 107 items and six sub-
scales; antisocial, self-absorbed, communication and anxi-
ety disturbance, disruptive, social relating and depressive. 
The DBC-A has high internal consistency (α = .95) and high 
test–retest reliability at two weeks for both paid carers and 
family carers at .75 and .85 respectively (Mohr et al. 2005).
The DBC-P and DBC-A are not directly comparable due 
to differing subscales. However, mean item scores, positively 
checked items and the intensity score of each measure can 
be calculated and combined (Taffe et al. 2008). This study 
examines the subscales for group differences but mainly 
focuses on the mean item score (sum of items divided by 
the number of items) and the intensity score (proportion of 
items scored as ‘very true of often true’). Whilst the DBC is 
generally regarded as categorical, the mean scores provide 
a dimensional measure of assessment.
Anxiety, Depression and Mood Scale
The Anxiety, Depression and Mood Scale (ADAMS; 
Esbensen et al. 2003) is an informant questionnaire com-
prising 28 items on four-point rating scales, with five sub-
scales; manic/hyperactive behaviour, depressed mood, social 
avoidance, general anxiety and compulsive behaviour. The 
questionnaire has been validated in individuals with ID 
aged 10–79 years and has good test–retest reliability (.81). 
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Internal consistency for the subscales and total score were 
calculated for this study and coefficients were high (manic 
hyperactive behaviour = .88, depressed mood = .88, social 
avoidance = .85, general anxiety = .87, compulsive behav-
iour = .83, total score = .93).
In this study, the ADAMS subscales were highly cor-
related with each other for every syndrome group, indicat-
ing high interrelatedness between categorical constructs 
(Online Resource A). Correlations between the ADAMS 
subscales and the DBC mean item and intensity score were 
also assessed. Overall, the measures were highly correlated, 
with the ADAMS total score significantly correlating with 
DBC mean item score  (rs = .80, p < .0001) and DBC intensity 
score  (rs = .67, p < .0001) (full table of correlations available 
in Online Resource B).
Sensory Experiences Questionnaire
The Sensory Experiences Questionnaire (SEQ; Baranek 
et al. 2006) is an informant questionnaire assessing sensory 
processing in daily tasks for children with autism and devel-
opmental delays. The items reflect five sensory domains: 
Gustatory-Olfactory, Tactile, Auditory, Visual and Vestib-
ular-Proprioceptive. Caregivers are asked to report the fre-
quency of sensory behaviours on a five-point scale; ‘almost 
never’ to ‘almost always’. The SEQ has excellent internal 
consistency, Cronbach’s alpha = .80 and test–retest reliabil-
ity, ICC = .92 (Little et al. 2011). This questionnaire has 
been utilised in samples including both children and adults 
with neurodevelopmental disorders (e.g, Kolacz et al. 2018). 
For the purpose of this study, only the auditory section of 
the SEQ was administered as this was the main domain of 
interest.
Procedure
Parents/carers were sent a link via email to online informa-
tion sheets and consent forms. Where consent was provided, 
the link directed individuals to the online survey study, con-
sisting of all the questionnaire measures. Participants aged 
16 or over with the capacity to consent were asked to com-
plete a paper consent form or provide consent through an 
online website link. The decision as to whether an individual 
was able to give consent was taken by the parent/carer and 
written information to provide guidance on how to assess 
capacity was provided by researchers.
Parents/carers of individuals aged 16 or over without the 
capacity to consent for themselves and parents/carers of 
individuals under 16 years old provided assent online or on 
paper. Breaks in the survey were included and paper copies 
were available on request. All participants taking part in the 
survey received an individualised feedback report.
Data Analysis
Missing data were prorated according to the assessment 
manuals or authors’ instructions. The sample collected for 
the DBC-P was too small to conduct statistical analyses, 
therefore only the DBC-A subscales or the combined DBC 
mean item score and intensity scores are presented in the 
analyses. All data were tested for normality using Shapiro 
Wilks tests. The use of parametric and non-parametric tests 
was chosen on a case by case basis, although the major-
ity of the data was not normally distributed. Kruskal–Wal-
lis tests with Dunn’s (1964) procedure post hoc tests, Chi 
square tests and one-way ANOVAs with Gabriel’s pairwise 
test procedure were utilised to assess group differences. Due 
to the large number of analyses, only group differences are 
presented. Partial eta squared (ηp2) and epsilon squared (ε2; 
see Fig. 1) were calculated to estimate effect sizes.
Interpretation of effect sizes was based on Cohen’s guide-
lines; small = .2, medium = .5, large = .8 (Cohen 1988). Mul-
tiple hierarchical regression analyses were then conducted 
to identify predictors of psychopathology. A hierarchical 
regression was chosen to allow for the inputting of the poten-
tial confounders (age and adaptive ability) in the first step 
of the analysis. This decision was based on the associations 
of these variables with other associated factors identified 
in the general population (Humes et al. 2013; Li and Lin-
denberger 2002). The inclusion of health and sensory pro-
cessing in the second step enabled the examination of the 
additional contribution of these variables in the prediction 
of psychopathology.
The majority of the data was normally distributed 
although some variables violated the assumption of homo-
scedasticity. To overcome this, bootstrapping with bias cor-
rected and accelerated 95% confidence intervals were used 
for all analyses. The data were assessed for outliers using 
Cook’s distance, casewise diagnostics, leverage and student 
deleted residuals. Data with high leverage were retained in 
the analyses, as it is suggested that this does not exert a 
large influence on regression coefficients (Field 2013). Indi-
vidual analyses were rerun excluding outliers and the results 
presented are without outliers as this did not significantly 
change results.
Assumption testing for the regression analyses are pre-
sented in Table  1. Durbin-Watson tests identified little 
2 =
( 2 − 1)/( + 1)
Fig. 1  Epsilon squared formula for Kruskal–Wallis tests as recom-
mended by Tomczak and Tomczak (2014)
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autocorrelation for each group. Multicollinearity was tested 
using variation inflation factors, which identified acceptable 
levels of correlation between predictors. The predictor ‘age’ 
violated the assumption of linearity for the WS group and 
data were transformed using inverse transformation for all 
groups.
A p value of .01 was chosen for the analyses to adjust for 
multiple comparisons. The use of a Bonferroni correction 
was viewed as too stringent and due to the exploratory nature 
of genetic syndrome research, it was considered of higher 
importance to prevent Type II errors and to identify pos-
sible relationships which could then be addressed in future 
research.
Results
Group Differences
Prior to other analyses, group differences in auditory 
sensory processing scores, health, age, gender, adaptive 
ability and psychopathology were examined(Table  2). 
There were no differences between the groups for age or 
adaptive ability, although there was an expected gender dif-
ference χ2(2) = 43.02, p = <.0001, Cramer’s V = .63, with 
the FXS group including more males (100%) than the WS 
(40%) and PWS (42%) groups. Auditory sensory process-
ing scores were significantly different between the groups 
(F(2107) = 19.67, ηp2 = .27, p < .0001). Pairwise comparisons 
revealed that individuals with WS (mean = 18.69) and FXS 
(17.69) had higher auditory processing impairments than 
individuals with PWS (13.19). Group differences were also 
found for overall lifetime health (χ2(2) = 23.90, ε2 = .22, 
p < .0001), with WS (74.74) scoring higher for health dif-
ficulties compared with FXS (40.52). For overall current 
health problems, significantly more health problems were 
found in WS (66.80) and PWS (62.85) compared with FXS 
(42.15) (χ2(2) = 15.15, ε2 = .14, p = .001).
To examine the profile of psychopathology in WS, 
FXS and PWS, group differences were assessed using 
the ADAMS and DBC assessment measures. Based on 
the ADAMS, general anxiety was the highest scoring 
domain for individuals with WS (median = 7.0, IR = 6.0, 
range = 0–21), social avoidance for individuals with FXS 
(median = 8.0, IR = 7.0, range = 2–17) and depressed mood 
for those with PWS (median = 5.0, IR = 7.0, range = 0–18) 
(for a full descriptive summary, see Online Resource C). 
Table 2 displays the group differences for the measures of 
psychopathology and the individual variables. There were 
group differences on the ADAMS for: 1) general anxiety 
(χ2(2) = 9.61, ε2 = .09, p = .008) with FXS (60.29) and WS 
(61.34) scoring higher than PWS (38.62), 2) manic/hyper-
active (χ2(2) = 10.16, ε2 = .09, p = .006) with FXS (65.87) 
scoring higher than PWS (43.02), and 3) social avoidance 
(χ2(2) = 37.13, ε2 = .34, p < .0001) with FXS (76.09) scoring 
Table 1  Autocorrelation and multicollinearity assumption testing for 
regression analyses
Durbin Watson 
mean (range)
Variation infla-
tion factors 
(range)
Williams syndrome 2.07
(1.84–2.33)
1.09–1.96
Fragile X syndrome 2.21
(1.65–2.68)
1.09–1.49
Prader–Willi syndrome 2.16
(1.48–2.74)
1.24–2.93
Table 2  Group differences for 
psychopathology and other 
variables between individuals 
with Williams syndrome, fragile 
X syndrome and Prader–Willi 
syndrome
m mean, SD standard deviation, med median, IR interquartile range
Domain WS FXS PWS Post-hoc
Gender Males % 40 100 42 FXS > PWS, WS
SEQ Auditory score m (SD)
range
18.7 (3.4)
13–25
17.6 (3.9)
10–26
13.2 (3.1)
8–20
FXS, WS > PWS
Health Lifetime overall scores med (IR)
range
9.0 (4.0)
2–22
5.0 (3.0)
0–16
6.0 (8.0)
1–23
WS > FXS
Current overall scores 3.0 (5.0)
0–12
0.0 (2.0)
0–16
2.0 (3.3)
0–19
PWS, WS > FXS
ADAMS General anxiety 7.0 (6.0)
0–21
7.5 (7.0)
0–20
4.0 (8.0)
0–12
FXS, WS > PWS
Manic hyperactive 4.0 (7.0)
0–12
7.0 (7.0)
0–14
3.0 (6.5)
0–12
FXS > PWS
Social avoidance 3.0 (5.0)
0–16
8.0 (7.0)
2–17
2.0 (5.3)
0–12
FXS > PWS, WS
DBC A Social relating 3.0 (4.0)
0–13
8.0 (4.8)
3–14
4.0 (4.0)
0–12
FXS > PWS, WS
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higher than WS (39.17) and PWS (38.67). On the DBC-A, 
only the social relating subscale differed between groups 
(χ2(2) = 26.96, ε2 = .32, p < .0001). Individuals with FXS 
(58.14) scored higher for social relating difficulties than 
individuals with PWS (34.93) and WS (27.28). There were 
no other differences between the groups on either measure.
Correlates of Psychopathology
To assess whether the full model of individual variables 
considered together was associated with psychological 
disturbance within syndromes, hierarchical regressions 
were conducted. The ANOVA models for the hierarchical 
regressions are presented in Table 3 (full models includ-
ing β coefficients and confidence intervals for individual 
predictors are available in Online Resource D). Step 1 of 
the regression model included age and adaptive functioning 
as predictors, and Step 2 included all factors; age, adaptive 
functioning, auditory sensory processing and health prob-
lems. The outcome variables included all the ADAMS sub-
scales (depressed mood, general anxiety, manic/hyperactive, 
obsessive compulsive, social avoidance) and the total score, 
and the DBC mean and intensity scores.
Williams Syndrome
In WS, the overall model of predictors was significant for 
every outcome variable, except for the obsessive–compul-
sive subscale (F(5,29) = 2.20, p = .081,  R2 = .28). For all 
other subscales, age and adaptive ability in Step 1 did not 
produce significant results, though the addition of health and 
sensory processing to the model in Step 2 led to statistically 
significant increases in the predictive ability of the model, 
which accounted for an additional 31–48% of the variance.
The influence of the individual predictors (age, adaptive 
ability, health difficulties and auditory sensory processing 
Table 3  Overall ANOVA models and  R2 for each scale of psychopathology for Williams syndrome, Fragile X syndrome and Prader–Willi syn-
drome
*p < .01; **p < .001; ***p < .0001
Total score Depressed mood Generalised 
anxiety
Manic 
hyperactiv-
ity
Obsessive 
compulsive
Social avoidance DBC mean 
item score
DBC intensity
Williams syndrome
 Step 1
  F statistic 1.30 1.14 .91 1.63 .73 1.29 2.91 2.50
  df (2,32) (2,31) (2,32) (2,32) (2,32) (2,31) (2,31) (2,31)
  R2 .08 .07 .05 .09 .04 .08 .16 .14
 Step 2
  F statistic 6.25*** 5.67* 4.77* 3.92* 2.20 7.12*** 8.16*** 5.92*
  df (5,29) (5,28) (5,29) (5,29) (5,29) (5,28) (5,28) (5,28)
  R2 .52 .50 .45 .40 .28 .56 .59 .51
Fragile X syndrome
 Step 1
  F statistic .35 .14 .07 1.80 1.26 1.28 4.86 2.38
  df (2,45) (2,43) (2,45) (2,45) (2,45) (2,45) (2,44) (2,43)
  R2 .02 .01 .00 .07 .05 .05 .18 .10
 Step 2
  F statistic 1.35 1.43 1.34 1.45 2.29 .74 5.01* 2.49
  df (5,42) (5,40) (5,42) (5,42) (5,42) (5,42) (5,41) (5,40)
  R2 .14 .15 .14 .15 .21 .08 .38 .24
Prader–Willi syndrome
 Step 1
  F statistic 3.97 4.00 3.37 5.31 1.41 2.08 2.70 2.19
  df (2,23) (2,22) (2,23) (2,23) (2,23) (2,23) (2,23) (2,23)
  R2 .26 .27 .19 .32 .11 .15 .19 .09
 Step 2
  F statistic 2.71 3.53 2.51 3.62 1.49 1.40 3.49 2.33
  df (5,20) (5,19) (5,20) (5,20) (5,20) (5,20) (5,20) (5,20)
  R2 .40 .48 .35 .48 .27 .26 .47 .37
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impairments) on the psychopathology scales is illustrated 
in Fig. 2. In WS, more current health problems were predic-
tive of higher DBC mean item score (b = .05 [95% CI: .02, 
.09], β = .52, p = .001) and DBC intensity (b = .02 [95% CI: 
.01, .04], β = .55, p = .009). Higher auditory sensory diffi-
culties significantly predicted a higher DBC mean (b = .04 
[95% CI: .01, .06], β = .50, p = .008) and higher scores on 
the ADAMS social avoidance subscale (b = .77 [95% CI: .41, 
1.04], β = .76, p = .001).
Prader–Willi Syndrome
For PWS, none of the overall models were significant and 
the addition of the predictors in Step 2 accounted for an 
additional 11–28% of the variance. For the individual pre-
dictors, higher adaptive ability was the only predictor of psy-
chopathology and significantly predicted a lower total score 
(b = − 1.41 [95% CI: − 2.26, − .43], β = − .56, p = .001), low-
ered generalised anxiety (b = − .37 [95% CI: − .63, − .04], 
β = − .52, p = .006) and manic/hyperactivity (b = − .38 [95% 
CI: − .59, − .13], β = − .59, p = .003) on the ADAMS.
Fragile X Syndrome
Only the overall model for the DBC mean item score for 
FXS was significant, (F(5,41) = 5.01, p = .001,  R2 = .38). 
The addition of health and sensory processing in Step 2 
accounted for an additional 3–20% of the variance across 
the outcome variables. The predictors for FXS differed from 
those for WS and PWS, with no associations identified for 
age, adaptive ability, health and auditory sensory processing.
With regard to overall level of psychopathology, audi-
tory sensory processing impairments and a higher number 
of health problems were associated with general psychiatric 
problems in individuals with WS; poorer adaptive ability 
was associated with psychopathology for individuals with 
PWS. No associations were identified between any of the 
individual predictors and psychopathology for individuals 
with FXS.
Discussion
This study is the first to examine differences in internal-
ising psychopathology and potential predictors of general 
psychopathology and specific symptoms in individuals with 
WS, FXS and PWS. These syndromes were chosen for com-
parison as they are broadly comparable for degree of ID. 
Exploratory analyses (p < .01) focused on associations with 
age, adaptive ability, health and auditory sensory processing. 
To examine the impact of methodological assessment on the 
results obtained, both dimensional and categorical measures 
Fig. 2  Predictors of psychopathology for Williams syndrome, Prader–Willi syndrome and Fragile X syndrome
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were used. The study identified cross-syndrome differences 
in: (1) health and auditory sensory processing, (2) psycho-
pathology generally and (3) correlates of psychopathology 
(both general psychopathology and specific symptoms).
Profiles of psychopathology and associated factors dif-
fered across groups. Higher rates of auditory sensory pro-
cessing impairments were found for individuals with WS 
and FXS compared with PWS; health difficulties were more 
prevalent in WS and PWS compared with FXS (small effect 
sizes). Consistent with our hypotheses and past research, 
generalised anxiety was significantly higher in FXS and WS 
compared with PWS, and both ADAMS and DBC social 
subscales were elevated in FXS compared with WS and 
PWS, although effect sizes were small. Our hypothesis that 
individuals with PWS would score higher on the compulsive 
behaviour subscale of the ADAMS was not supported. The 
high proportion of adults in this study (80% aged over 18) 
may account for this non-significant finding, as there is some 
evidence that compulsive behaviour decreases with age in 
PWS (Dykens 2004).
Cross-syndrome comparisons of correlates of psycho-
pathology were also examined. Age was not predictive of 
psychopathology for any of the syndrome groups, consist-
ent with several studies in the literature (Dykens and Kasari 
1997; Hessl et  al. 2001; Woodruff-Borden et al. 2010). 
However, as noted above, participants in this study were 
predominantly adults and thus the somewhat restricted age 
range, together with small samples sizes, may have reduced 
correlations with age. Larger samples including a broader 
age range are needed to provide further information on this 
relationship.
Associations with Adaptive and Intellectual 
Functioning
Adaptive functioning did not predict psychopathology for 
FXS or WS, however poorer adaptive functioning was 
associated with total psychopathology, general anxiety and 
manic/hyperactive behaviour in individuals with PWS. PWS 
is caused by three genetic mechanisms, deletion, maternal 
uniparental disomy and imprinting defects (Cassidy et al. 
2011). The deletion subtype has been associated with poorer 
adaptive functioning than the other subtypes (Butler et al. 
2004) and since half of the sample in the study presented 
with the deletion subtype, this may have inflated the find-
ings. However, despite this potential confound, the majority 
of research suggests limited differentiation in clinical fea-
tures between the different PWS subtypes (Cassidy et al. 
2011).
The findings in this study have general implications 
for identifying the underlying causes of psychopathology 
for WS, PWS and FXS. Some psychiatric difficulties in 
PWS seem to be associated with adaptive skills, whereas 
psychopathology in FXS and WS seems to be independent of 
ID or adaptive functioning and may be more phenotypically 
driven. This is generally consistent with existing literature 
suggesting that intellectual functioning is unrelated to the 
development of psychopathology in WS and FXS (Dodd 
and Porter 2009; Cordeiro et al. 2011; Stinton et al. 2010; 
Vasa et al. 2013). Whilst adaptive functioning has received 
limited attention, this study confirms a lack of association 
between adaptive ability and psychopathology in these two 
groups, consistent with previous cognitive and mental health 
research. In PWS, future research with larger samples and 
the consideration of each genetic subtype individually may 
further elucidate the association between psychopathology 
and adaptive functioning.
Associations with Health Problems and Auditory 
Sensory Processing
This study is the first to identify an association between 
health and psychopathology in WS. Individuals with WS 
reported the highest number of health problems and current 
health difficulties were predictive of level and intensity of 
emotional disturbance, as measured by the DBC. Auditory 
sensory processing impairments were also only predictive 
of psychopathology for the WS group and were not predic-
tive in individuals with FXS, despite these groups scoring at 
similar levels on the auditory subscale of the SEQ.
These findings suggest that difficulties with auditory sen-
sory processing, such as the presence of hyperacusis, could 
be a specific risk marker for general psychopathology in 
individuals with WS. Hyperacusis is reported to affect up 
to 80% of individuals with WS (Levitin et al. 2005), hence 
this may partly contribute to the high rates of psychopa-
thology reported in this syndrome. An association between 
social avoidance and sensory processing was also identified 
in participants with WS. Social anxiety has been associ-
ated with sensory processing sensitivities in clinical sam-
ples of individuals with social anxiety disorder and has also 
been identified in individuals with autism spectrum condi-
tion (Hilton et al. 2007; Hofmann and Bitran 2007). Future 
research is needed to investigate the relationship between 
sensory processing, social impairments and anxiety in WS 
and to explore how, and why, sensory processing problems 
appear to predispose to psychopathology in WS but not FXS.
It is notable that associations between psychopathology 
and health and sensory processing were identified in WS 
but not in the other two syndromes, contrary to expectation 
and despite a comparably high prevalence of health difficul-
ties in PWS and auditory sensory impairments in FXS. The 
lack of significant associations between these variables in 
FXS and PWS suggests that these factors are not strongly 
implicated in the development of mental health problems for 
these groups. Instead, alternative predictors, not examined in 
Journal of Autism and Developmental Disorders 
1 3
this study, may play an influential role, such as the presence 
of autism (Hatton et al. 2002). These findings also suggest 
the presence of these characteristics alone are insufficient to 
influence psychopathological development and there may 
be additional biological processes in individuals with WS 
that interact with these variables to increase susceptibility 
to psychopathology. This, coupled with increased exposure 
to aversive health and sensory related experiences, may 
increase the risk for developing psychopathology in people 
with WS.
It is evident that the disparities in mental health correlates 
between genetic syndrome requires further extensive investi-
gation. The identification of specific correlates has important 
implications for the understanding of causal pathways and 
the influence of risk factors for psychopathology in these 
groups. Further research in this area will also be essential to 
inform early intervention, which should be targeted towards 
addressing these predictors to reduce the onset and severity 
of subsequent mental health problems.
Assessment Measures
The study demonstrates the importance of consideration 
of the measures used to assess psychopathology in genetic 
syndromes. The association between psychopathology 
and adaptive behaviour in PWS was only identified on the 
ADAMS subscales; no relationships were found on the 
DBC. Similarly, in WS, current health problems were pre-
dictive of psychopathology as measured by the DBC, but not 
when measured by the ADAMS. This indicates that results 
from studies using single approaches should be interpreted 
with caution and the influence of specific assessment meth-
odologies on research findings should always be carefully 
considered. These findings also highlight the necessity for 
the use of multi-assessment approaches when examining 
psychopathology and potential correlates or risk markers.
Limitations
There are several limitations of the study that should be 
taken into consideration. Firstly, assessments of psycho-
pathology were based on questionnaire data, not clinical 
diagnosis. Whilst this methodology was chosen to provide 
continuous scores of the main topographies of psychopa-
thology, and provides an indication of whether individuals 
may be experiencing clinically relevant disorders, it is nei-
ther as detailed nor robust as a clinical diagnostic assess-
ment. Moreover, the sample sizes were uneven between 
the groups and may be considered small for the regression 
analyses conducted. However, according to Austin and Stey-
erberg (2015), two participants per variable is adequate to 
estimate regression coefficients. Under these guidelines and 
the through the use of bootstrapping, the sample sizes were 
considered adequate for the use of this analysis, although 
larger sample sizes are always preferred to ensure a greater 
level of statistical power. Larger samples may also help to 
overcome the small effect sizes identified for the significant 
results found in this study. Due to the exploratory nature of 
the study, the p-value chosen increases the probability of a 
type I error, hence results should be interpreted with this 
consideration.
In addition, this study utilised cross-sectional methodol-
ogy whereas longitudinal research is needed to demonstrate 
the associations between predictors and mental health dif-
ficulties over time. The study also utilised a sample with 
a wide age range, however psychopathology may follow 
a developmental trajectory in these groups and the inclu-
sion of children and adults in the sample does not allow for 
the exploration of age specific outcomes. Even so, age was 
included as a potential confound in Step 1 of the regression 
analysis and did not produce any significant results. Other 
studies examining the effects of age for these syndromes 
have also found limited results (Dykens and Kasari 1997; 
Hessl et al. 2001; Stinton et al. 2010), suggesting this may 
not be a significant concern. Finally, any voluntary question-
naire studies of this kind are prone to substantial bias (Kei-
ding and Louis 2016); it is not known what proportion of 
families who had access to the surveys did respond, or how 
data from non-responders might have affected the findings.
Despite these caveats, we identified significant and poten-
tially important cross-syndrome differences in the correlates 
of psychopathology for individuals with WS, PWS and FXS. 
Current health problems and auditory sensory processing 
deficits were associated with psychiatric disturbance for 
individuals with WS, and poorer adaptive functioning was 
predictive of higher psychopathology for individuals with 
PWS. None of the variables examined was predictive of 
psychopathology in FXS. This study highlights the need for 
continued research into risk markers, utilising a combination 
of approaches and the development of targeted syndrome-
specific interventions to reduce and manage psychopatho-
logical disorders.
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